tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
CLOV is currently covered by 3 analysts with an average price target of $4.66. This is a potential upside of $1.26 (37.06%) from yesterday's end of day stock price of $3.4.
Clover Health Investments Corp's activity chart (see below) currently has 19 price targets and 17 ratings on display. The stock rating distribution of CLOV is 40% HOLD and 60% BUY.
Analysts average stock forecasts to be materialized ratio is 85.19% with an average time for these price targets to be met of 148.89 days.
Highest price target for CLOV is $4.5, Lowest price target is $4, average price target is $4.25.
Most recent stock forecast was given by RICHARD CLOSE from CANACCORD on 02-Mar-2025. First documented stock forecast 01-Feb-2021.
Currently out of the existing stock ratings of CLOV, 2 are a HOLD (40%), 3 are a BUY (60%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$4.5
$0.99 (28.21%)
$3.2
2 months 11 days ago
(02-Mar-2025)
3/6 (50%)
$0.86 (23.63%)
277
Hold
$4
$0.49 (13.96%)
$3
7 months 7 days ago
(07-Oct-2024)
3/3 (100%)
$0.31 (8.40%)
25
Hold
$1.8
$-1.71 (-48.72%)
$3.5
2 years 5 months 28 days ago
(15-Nov-2022)
2/3 (66.67%)
$0.43 (31.39%)
683
Hold
$1.5
$-2.96 (-66.37%)
$3
2 years 6 months 5 days ago
(08-Nov-2022)
4/4 (100%)
$0.21 (16.28%)
36
$3
$2.1 (233.33%)
3 years 3 months 11 days ago
(02-Feb-2022)
2/2 (100%)
$0.25 (9.09%)
81
What is CLOV (Clover Health Investments Corp) average time for price targets to be met?
Which analyst has the current highest performing score on CLOV (Clover Health Investments Corp) with a proven track record?
Which analyst has the current lower performing score on CLOV (Clover Health Investments Corp) with a proven track record?
Which analyst has the most public recommendations on CLOV (Clover Health Investments Corp)?
Which analyst is the currently most bullish on CLOV (Clover Health Investments Corp)?
Which analyst is the currently most reserved on CLOV (Clover Health Investments Corp)?
